Mayne Pharma Financials
| MAYNF Stock | USD 2.62 0.01 0.38% |
Mayne |
Mayne Pharma Stock Summary
Mayne Pharma competes with Bristol Myers, AbbVie, Merck, Gilead Sciences, and Johnson Johnson. Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia. Mayne Pharma operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 1538 Main North |
| Sector | Healthcare |
| Industry | Drug Manufacturers—General |
| Benchmark | Dow Jones Industrial |
| Website | www.maynepharma.com |
| Phone | 61 8 8209 2666 |
| Currency | USD - US Dollar |
Mayne Pharma Key Financial Ratios
There are many critical financial ratios that Mayne Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Mayne Pharma Group reports annually and quarterly.Mayne Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mayne Pharma's current stock value. Our valuation model uses many indicators to compare Mayne Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mayne Pharma competition to find correlations between indicators driving Mayne Pharma's intrinsic value. More Info.Mayne Pharma Group is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mayne Pharma's earnings, one of the primary drivers of an investment's value.Mayne Pharma Group Systematic Risk
Mayne Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Mayne Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-five with a total number of output elements of sixteen. The Beta measures systematic risk based on how returns on Mayne Pharma Group correlated with the market. If Beta is less than 0 Mayne Pharma generally moves in the opposite direction as compared to the market. If Mayne Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Mayne Pharma Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Mayne Pharma is generally in the same direction as the market. If Beta > 1 Mayne Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Mayne Pharma January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Mayne Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Mayne Pharma Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mayne Pharma Group based on widely used predictive technical indicators. In general, we focus on analyzing Mayne Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mayne Pharma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 15.69 | |||
| Value At Risk | (4.76) | |||
| Potential Upside | 4.94 |
Complementary Tools for Mayne Pink Sheet analysis
When running Mayne Pharma's price analysis, check to measure Mayne Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mayne Pharma is operating at the current time. Most of Mayne Pharma's value examination focuses on studying past and present price action to predict the probability of Mayne Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mayne Pharma's price. Additionally, you may evaluate how the addition of Mayne Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |